European Journal of Epidemiology · 2021 · 36 citations · 35 references
MedicineOncologyAgingCancer EpidemiologyEpidemiologyCancer BiomarkersCancer Epidemiology In Older AdultsCancer MortalityCancer RiskRisk Factor EpidemiologyAge-related Cancer RiskAge-specific Cancer IncidenceAge-specific Risk AssessmentBiomarkers Of Cancer RiskCancer Risk AssessmentCancer Risk AssociationCardiovascular Disease IncidenceLung Cancer Risk
Abstract Biological age is an important risk factor for chronic diseases. We examined the associations between five markers of unhealthy ageing; Growth Differentiation Factor-15 (GDF-15), N-terminal pro-brain natriuretic peptide (NT-proBNP), glycated hemoglobin A1c (HbA1C), C-Reactive Protein (CRP) and cystatin-C; with risks of cancer and cardiovascular disease (CVD). We used a case-cohort design embedded in the EPIC-Heidelberg cohort, including a subcohort of 3792 participants along with 4867 incident cases of cancer and CVD. Hazard ratios (HRs) were computed and the strongest associations were used to build weighted multi-marker combinations, and their associations with cancer and CVD risks were tested. After adjusting for common confounders, we observed direct associations of GDF-15 with lung cancer risk, NT-proBNP with breast, prostate and colorectal cancers, HbA1C with lung, colorectal, and breast cancer risks, and CRP with lung and colorectal cancer risks. An inverse association was observed for GDF-15 and prostate cancer risk. We also found direct associations of all 5 markers with myocardial infarction (MI) risk, and of GDF-15, NT-proBNP, CRP and cystatin-C with stroke risk. A combination of the independently-associated markers showed a moderately strong association with the risks of cancer and CVD (HR Q4-Q1 ranged from 1.78[1.36, 2.34] for breast cancer, when combining NT-proBNP and HbA1C, to 2.87[2.15, 3.83] for MI when combining NT-proBNP, HbA1C, CRP and cystatin-C). This analysis suggests that combinations of biomarkers related to unhealthy ageing show strong associations with cancer risk, and corroborates published evidence on CVD risk. If confirmed in other studies, using these biomarkers could be useful for the identification of individuals at higher risk of age-related diseases.
35
Theo Vos, Stephen S Lim, Cristiana Abbafati et al. · The Lancet · 2020 · 19.2K citations · Full text
Geroscience: Linking Aging to Chronic Disease
Brian K. Kennedy, Shelley L. Berger, Anne Brunet et al. · Cell · 2014 · 2.7K citations · Full text
Education, Geriatric Medicine, Aging +11
Metformin improves healthspan and lifespan in mice
Alejandro Martín‐Montalvo, Evi M. Mercken, Sarah J. Mitchell et al. · Nature Communications · 2013 · 1.4K citations · Full text
Undulating changes in human plasma proteome profiles across the lifespan
Benoit Lehallier, David Gate, Nicholas Schaum et al. · Nature Medicine · 2019 · 986 citations · Full text